Topic: settlement

EpiPen new

UPDATED: Mylan strikes $465M deal with DOJ on EpiPen rebates

In what may be a record speed for a Justice Department settlement, Mylan has cut a deal to pay $465 million to resolve allegations that it overcharged Medicaid for EpiPen. Investors cheered the news, but analysts and politicians both say the EpiPen fallout is far from over.

Pricey 'doc-in-a-box' dinners put Salix on DOJ's naughty list

Need more evidence that pharma’s fancy dinners with doctors don’t automatically count as educational events? Check out the details behind Valeant Pharmaceuticals’ recent settlement with the Justice Department, over its Salix unit’s gastrointestinal drug marketing.
AstraZeneca HQ

AstraZeneca, Ranbaxy settle Nexium fight

AstraZeneca investors were jumping for joy this morning when the drugmaker announced it had played Let's Make a Deal with Indian generics maker Ranbaxy. The copycat company agreed to wait till 2014